GlassScriptPhysician profile
Gregory D Trachiotis
NPI 1114938081
$9,773.45
in general payments reported to CMS, 2019-2025
14 companies · $540 in 2025
The $540 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,504 · 2020: $1,739 · 2021: $1,158 · 2022: $717 · 2023: $1,772 · 2024: $1,343 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,655.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,766.99 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $2,418.44 | 2019-2020 | |
| Medistim USA, INC. | $1,556.78 | 2019-2024 | Miraq |
| Abbott Laboratories | $532.92 | 2021-2025 | Navitor, Mitraclip, Ensite |
| Ethicon INC. | $371.50 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $327.12 | 2019-2023 | Ofev |
| Atricure, INC. | $129.38 | 2024-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Amgen INC. | $118.05 | 2023 | Tezspire |
| Astrazeneca Pharmaceuticals LP | $118.05 | 2023 | Tezspire |
| E.R. Squibb & Sons, L.L.C. | $109.68 | 2021 | |
| Genzyme Corporation | $102.46 | 2019 | |
| Cvrx, INC. | $100.75 | 2024 | Barostim Neo System |
| Medtronic, INC. | $83.64 | 2022-2024 | Signia, Sonicision |
| Getinge USA Sales, LLC | $37.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Trachiotis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.